Quanterix Corporation operates as a life sciences technology enterprise dedicated to advancing scientific discovery and clinical diagnostics through ultra-sensitive protein biomarker detection. The company designs, manufactures, and commercializes sophisticated laboratory instruments, consumables, and assay kits that enable researchers and clinicians to measure low-abundance biological molecules in blood and other fluids that traditional testing methods cannot detect. By bridging basic medical research and clinical applications, Quanterix focuses on unlocking early disease detection years before conventional symptoms physically manifest.